Technical Analysis for NBY - NovaBay Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 0.715 8.80% 0.06
NBY closed down 0.71 percent on Monday, May 17, 2021, on 36 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical NBY trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 8.79%
Stochastic Buy Signal Bullish 8.79%
Lower Bollinger Band Walk Weakness 8.79%
Wide Bands Range Expansion 8.79%
Oversold Stochastic Weakness 8.79%
Lower Bollinger Band Walk Weakness 8.02%
Inside Day Range Contraction 8.02%
Lower Bollinger Band Touch Weakness 8.02%
Oversold Stochastic Weakness 8.02%
Lower Bollinger Band Walk Weakness 16.47%
Older End-of-Day Signals for NBY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1 ATR 10 minutes ago
10 DMA Resistance about 2 hours ago
60 Minute Opening Range Breakout about 2 hours ago
Rose Above Previous Day's High about 2 hours ago
Rose Above 10 DMA about 2 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


NovaBay Pharmaceuticals, Inc. Description

NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the development of various product candidates for the therapeutic needs of the anti-infective market. The company operates in four segments: Dermatology, Ophthalmology, Urology, and Wound Care. It has categories of compounds, Aganocides and NeutroPhase. The company's Aganocide compounds comprise NVC-422 that is in Phase IIb clinical study for the treatment of adenoviral conjunctivitis, a contagious viral eye infection; impetigo, a highly contagious skin infection; and urinary catheter blockage and encrustation, and associated urinary tract infections. Its NeutroPhase product is a hypochlorous acid solution, has approved for the treatment of patients who suffer from chronic non-healing wounds, such as pressure, venous stasis, and diabetic ulcers. The company has collaboration and license agreement with Galderma S.A. to develop and commercialize its Aganocide compounds, which covers acne, impetigo, and other dermatological conditions. It also has strategic marketing agreement with Pioneer Pharma Co., Ltd. to market its pharmaceutical products in China and other Asian markets. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Acid Eye Pharmaceutical Products Catheter Urology Ophthalmology Wound Dermatology Ulcer Healing Acne Urinary Tract Infection Urinary Tract Infections Viral Conjunctivitis

Is NBY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 1.94
52 Week Low 0.51
Average Volume 1,331,294
200-Day Moving Average 0.85
50-Day Moving Average 0.86
20-Day Moving Average 0.75
10-Day Moving Average 0.71
Average True Range 0.06
ADX 22.32
+DI 15.21
-DI 26.12
Chandelier Exit (Long, 3 ATRs ) 0.66
Chandelier Exit (Short, 3 ATRs ) 0.78
Upper Bollinger Band 0.86
Lower Bollinger Band 0.63
Percent B (%b) 0.11
BandWidth 31.09
MACD Line -0.06
MACD Signal Line -0.05
MACD Histogram -0.0066
Fundamentals Value
Market Cap 27.46 Million
Num Shares 41.8 Million
EPS -0.58
Price-to-Earnings (P/E) Ratio -1.13
Price-to-Sales 2.06
Price-to-Book 1.93
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.72
Resistance 3 (R3) 0.73 0.71 0.71
Resistance 2 (R2) 0.71 0.69 0.71 0.71
Resistance 1 (R1) 0.68 0.68 0.68 0.68 0.71
Pivot Point 0.67 0.67 0.66 0.66 0.67
Support 1 (S1) 0.64 0.65 0.63 0.63 0.61
Support 2 (S2) 0.62 0.64 0.62 0.61
Support 3 (S3) 0.60 0.62 0.60
Support 4 (S4) 0.59